Spatiotemporal control of cell cycle acceleration during axolotl spinal cord regeneration

  1. Emanuel Cura Costa
  2. Leo Otsuki
  3. Aida Rodrigo Albors
  4. Elly M Tanaka
  5. Osvaldo Chara  Is a corresponding author
  1. National Scientific and Technical Research Council (CONICET) and University of La Plata (UNLP), Argentina
  2. Vienna Biocenter (VBC), Austria
  3. University of Dundee, United Kingdom
  4. Technische Universität Dresden, Germany

Abstract

Axolotls are uniquely able to resolve spinal cord injuries, but little is known about the mechanisms underlying spinal cord regeneration. We previously found that tail amputation leads to reactivation of a developmental-like program in spinal cord ependymal cells (Rodrigo Albors et al., 2015), characterized by a high-proliferation zone emerging 4 days post-amputation (Rost et al., 2016). What underlies this spatiotemporal pattern of cell proliferation, however, remained unknown. Here, we use modelling, tightly linked to experimental data, to demonstrate that this regenerative response is consistent with a signal that recruits ependymal cells during ~85 hours after amputation within ~830mm of the injury. We adapted FUCCI technology to axolotls (AxFUCCI) to visualize cell cycles in vivo. AxFUCCI axolotls confirmed the predicted appearance time and size of the injury-induced recruitment zone and revealed cell cycle synchrony between ependymal cells. Our modeling and imaging move us closer to understanding bona fide spinal cord regeneration.

Data availability

Jupyter Notebook (http://jupyter.org/) containing the source code for all computations performed and referred to as Cura Costa et al., 2021 in this study can be found at https://doi.org/10.5281/zenodo.4557840

Article and author information

Author details

  1. Emanuel Cura Costa

    Systems Biology Group (SysBio), Institute of Physics of Liquids and Biological Systems (IFLySIB), National Scientific and Technical Research Council (CONICET) and University of La Plata (UNLP), La Plata, Argentina
    Competing interests
    The authors declare that no competing interests exist.
  2. Leo Otsuki

    The Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6107-2508
  3. Aida Rodrigo Albors

    Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9573-2639
  4. Elly M Tanaka

    The Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4240-2158
  5. Osvaldo Chara

    Center for Information Services and High Performance Computing, Technische Universität Dresden, Dresden, Germany
    For correspondence
    osvaldo.chara@tu-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0868-2507

Funding

Agencia Nacional de Promoción Científica y Tecnológica (PICT 2014-3469)

  • Osvaldo Chara

Agencia Nacional de Promoción Científica y Tecnológica (PICT 2017-2307)

  • Osvaldo Chara

Agencia Nacional de Promoción Científica y Tecnológica (PICT-2019-2019-03828)

  • Osvaldo Chara

Consejo Nacional de Investigaciones Científicas y Técnicas (Doctoral Student Fellowship)

  • Emanuel Cura Costa

ERC Advanced Grant (742046)

  • Elly M Tanaka

Human Frontier Science Program (fellowship LT000785/2019-L.)

  • Leo Otsuki

European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie grant agreement No 753812)

  • Aida Rodrigo Albors

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The licenses necessary for work with genetically modified organisms (GMOs) and for experiments specifically involving axolotls (Ambystoma mexicanum) were obtained from the relevant authorities and have been implemented at the IMP in accordance with applicable international, EU and national (Austrian) guidelines.The license for work with GMOs at safety levels 1 and 2 was approved by the GMO office of the Austrian authorities and was issued on 16/03/2017 with no end date (BMGF‐76110/0017‐ II/B/16c/2017).The axolotl research license numbers are GZ: 51072/2019/16 (valid 09/05/2019 - 28/02/2024) and GZ: MA58/665226/2019/21 (valid 24.02.2020 - 30.09.2024). These are approved by the City of Vienna, MA58.There is a dedicated veterinarian for the animal facility, as well as an animal welfare consultant. Animal facility inspections are performed yearly by the City of Vienna, MA58 and the animal licenses and animal husbandry conditions are updated in dialogue with animal welfare authorities.Axolotls (Ambystoma mexicanum) were raised in individual aquaria. Axolotl breedings were performed by the IMP animal facility. All experiments were performed in accordance with locally applicable ethics committee guidelines and within a framework agreed with the Magistrate of Vienna (Austria). Axolotls were anaesthetized with benzocaine (Sigma) diluted in tap water prior to amputation and/or imaging, to minimize suffering.

Copyright

© 2021, Cura Costa et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,226
    views
  • 563
    downloads
  • 30
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emanuel Cura Costa
  2. Leo Otsuki
  3. Aida Rodrigo Albors
  4. Elly M Tanaka
  5. Osvaldo Chara
(2021)
Spatiotemporal control of cell cycle acceleration during axolotl spinal cord regeneration
eLife 10:e55665.
https://doi.org/10.7554/eLife.55665

Share this article

https://doi.org/10.7554/eLife.55665

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Aida Rodrigo Albors, Akira Tazaki ... Elly M Tanaka
    Research Article Updated

    Axolotls are uniquely able to mobilize neural stem cells to regenerate all missing regions of the spinal cord. How a neural stem cell under homeostasis converts after injury to a highly regenerative cell remains unknown. Here, we show that during regeneration, axolotl neural stem cells repress neurogenic genes and reactivate a transcriptional program similar to embryonic neuroepithelial cells. This dedifferentiation includes the acquisition of rapid cell cycles, the switch from neurogenic to proliferative divisions, and the re-expression of planar cell polarity (PCP) pathway components. We show that PCP induction is essential to reorient mitotic spindles along the anterior-posterior axis of elongation, and orthogonal to the cell apical-basal axis. Disruption of this property results in premature neurogenesis and halts regeneration. Our findings reveal a key role for PCP in coordinating the morphogenesis of spinal cord outgrowth with the switch from a homeostatic to a regenerative stem cell that restores missing tissue.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.